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Cognitive Impairment and Dementia in Chinese Parkinson’s Disease 
Vincent Mok
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong SAR
Background: The	incidence	of	dementia	in	Parkinson’s	disease	(PD)	among	Caucasians	varies	between	42.6	
and	112.5	per	1000	person-years.	Since	genetic	and	cultural	factors	may	affect	manifestation	of	dementia,	
incidence	of	dementia	among	Chinese	PD	patients	may	differ	to	that	of	Caucasian	PD	patients.	We	aimed	
to	study	the	incidence	and	predictors	of	dementia	among	Chinese	PD	patients.	To	date,	such	data	are	not	
available	in	the	literature.	
Method: A	total	of	132	Chinese	PD	subjects	(mean	age	59.7	±	9.1	years;	male	67.4%)	participated	in	this	
study.	These	subjects	were	participants	of	a	clinical	study.1	At	baseline,	all	subjects	were	not	demented	
and	Chinese	mini-mental	state	examination	(MMSE)	score	was	obtained.	We	performed	cognitive	
assessment	3.5	years	later.	We	defined	dementia	according	to	the	Movement	Disorder	Society	Task	Force	
Clinical	Diagnostic	Criteria	for	PD	dementia.2	We	defined	significant	cognitive	decline	as	a	drop	of	MMSE	
score	of	≥3.	We	investigated	the	association	between	putative	baseline	factors	and	incident	significant	
cognitive	decline	and	dementia.	
Results: Nine	subjects	(6.8%;	incidence	rate	of	20.0	per	1000	person-years)	developed	dementia	and	29	
(22%)	subjects	had	significant	cognitive	decline	at	the	end	of	follow-up.	Multivariate	analysis	showed	that	
age	(odds	ratio=1.4;	95%	confidence	interval,	1.01-1.28),	speech	impairment	(6.5;	1.60-26.48),	and	impaired	
pentagon	copying	(11.29;	3.31-38.50)	were	 independent	predictors	for	 incident	significant	cognitive	
decline	and	dementia.
Conclusion: Incidence	of	dementia	in	Chinese	PD	is	 lower	compared	with	that	 in	Caucasian	PD.	Age,	
speech	impairment,	and	impaired	pentagon	drawing	are	predictors	for	 incident	significant	cognitive	
decline	and	dementia.	
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Central	nervous	system	inflammatory	demyelinating	disorders (CNS	IDD)	include	classical	multiple	
sclerosis,	neuromyelitis	optica	(NMO)	spectrum	disorders,	a	single	attack	of/recurrent	acute	disseminated	
encephalomyelitis,	a	single	attack	of	 idiopathic	acute	 transverse	myelitis,	optic	neuritis	 (ON)	and	
brainstem	encephalitis.	CNS	IDD	are	potentially	serious	disorders	with	risks	of	mortality	and	significant	
disability.	Typical	relapsing	forms	of	CNS	IDD	are	relapsing	remitting	multiple	sclerosis	and	relapsing	
NMO.	Relapsing	NMO	is	typified	by	recurrent	longitudinally	extensive	transverse	myelitis	and	severe	
unilateral	or	bilateral	ON.	Early	diagnosis	of	CNS	IDD	is	important	as	long-term	treatment	for	different	
forms	varies.	Recognition	of	clinical,	radiological	and	serological	characteristics	of	different	forms	of	
CNS	IDD	facilitates	early	diagnoses.	A	significant	proportion	of	NMO	patients	are	seropositive	for	
autoantibodies	against	aquaporin-4,	the	most	abundant	water	channel	 in	the	CNS;	this	supports	the	
hypothesis	that	NMO	is	an	autoimmune	disorder.	Is	NMO	an	autoantibody-mediated	disorder	sharing	
similar	pathogenesis	with	myasthenia	gravis	 (MG),	a	classical	autoantibody-mediated	autoimmune	
disease?	An	interesting	observation	is	that	paraneoplastic	NMO	associated	various	tumours	is	recognised	
recently,	suggesting	similarity	with	MG	which	is	associated	with	thymoma	in	about	15	to	20%	of	patients.	
